We first tested if the burden of rare protein-altering variants (defined as minor allele frequency [MAF] < 1%) in PRKN and LRRK2 differed between the 203 T1R-affected vs 200 T1R-free leprosy patients that had not been included in the previous study. Here, PRKN is linked to leprosy.